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Abstract. Mining gene expression profiles has proven valuable for identifying 
signatures serving as surrogates of cancer phenotypes. However, the similarities 
of such signatures across different cancer types have not been strong enough to 
conclude that they represent a universal biological mechanism shared among 
multiple cancer types. Here we describe a network-based approach that explores 
gene-to-gene connections in multiple cancer datasets while maximizing the 
overall association of the subnetwork with clinical outcomes. With the dataset 
of The Cancer Genome Atlas (TCGA), we studied the characteristics of com-
mon gene expression of three types of cancers: Rectum adenocarcinoma 
(READ), Breast invasive carcinoma (BRCA) and Colon adenocarcinoma 
(COAD). By analyzing several pairs of highly correlated genes after filtering 
and clustering work, we found that the co-expressed genes across multiple types 
of cancers point to particular biological mechanisms related to cancer cell pro-
gression, suggesting that they represent important attributes of cancer in need of 
being elucidated for potential applications in diagnostic, prognostic and thera-
peutic products applicable to multiple cancer types. 
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1 Introduction 
Cancer is known to be not just one disease, but many diseases, as evidenced by the 
diversity of its pathological manifestations. With the goal of clinically stratifying 
samples into risk groups, several gene expression biomarkers have been proposed for 
a large variety of cancer types [1, 2]. Most biomarkers have been identified and de-
signed for a specific type of cancer, but it has been appreciated that there exist some 
unifying capabilities or “hallmarks” that can be used as tumor markers, characterizing 
all cancers because they exhibit similar biomolecular phenotypes [3]. Furthermore, it 
has been recognized that gene expression signatures resulting from analysis of cancer 
datasets can serve as surrogates of cancer phenotypes [4]. Therefore, it is reasonable 
to hypothesize that computational analysis of rich biomolecular cancer datasets may 
reveal signatures that are shared across many cancer types and are associated with 
specific cancer phenotypes, and are related to sustaining proliferative, insensitivity to 
anti-growth signals, metastasis, and etc [3].  
Gene expression signatures that can be applied for a broad range of cancers could 
be highly useful in research and clinical settings. In clinics, such signatures may serve 
as a standard assessment for facilitating the interpretation and broad application of 
laboratory test results, simplifying laboratory protocols, and reducing costs. In re-
search, these signatures may help to elucidate broadly observed biological mecha-
nisms and possible drug targets [8].  
With the availability of rich data sets from many different cancer types provides an 
opportunity for thorough computational data mining in search of such common pat-
terns. Distinct algorithms and strategies have been used to identify common gene 
expression signatures: regulatory network [5], clustering approaches [6] and other 
related techniques. In this paper, we use gene co-expression network and develop a 
statistical method of common gene expression signature analysis for multiple types of 
cancer.  
Previous research evaluates such common patterns within a couple of cancer types 
[7, 8], but never explore the following three cancer types together: Colon adenocarci-
noma (COAD), Rectum adenocarcinoma (READ) and Breast invasive carcinoma 
(BRCA). In this paper, we use the above three types of cancer for experiment.  Our 
purpose is to identify gene expression pattern across multi-cancers, and reveal hall-
marks of cancer, and thus helps to find bio-markers associated with different types of 
cancer, and contributes to the prognosis of cancer. 
2 Method 
A co-expression network identifies which genes have a tendency to show a coordinat-
ed expression pattern across a group of samples. This co-expression network can be 
represented as a gene–gene similarity matrix, which can be used in downstream anal-
yses [9]. Canonical co-expression network construction and analyses can be described 
with the following three steps.  
To begin with, one needs to define a measure of similarity between the gene ex-
pression profiles. This similarity measures the level of concordance between gene 
expression profiles across the experiments. Individual relationships between genes are 
defined based on correlation measures [29] or mutual information [10] between each 
pair of genes. Different measures of correlation have been used to construct networks, 
including Pearson’s or Spearman’s correlations [11]. Alternatively, least absolute 
error regression [12] or a Bayesian approach [13] can be used to construct a co-
expression network [14]. In this paper, we use the commonly used Pearson’s correla-
tion as follows: 
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where 𝜎𝑥 is the standard deviation of x and 𝜎𝑦is the standard deviation of y.
In the second step, co-expression associations are used to construct a network 
where each node represents a gene and each edge represents the presence and the 
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strength of the co-expression relationship [15]. In order to filter out the genes that are 
not related to cancer, we select genes expressed differently between cancer samples 
and normal samples with T-test. To get the common gene expression signatures, we 
choose the genes existed in all the types of cancer samples. 
In the third step, modules (groups of co-expressed genes) are identified using one 
of several available clustering techniques. Clustering in co-expression analyses is 
used to group genes with similar expression patterns across multiple samples to pro-
duce groups of co-expressed genes rather than only pairs. The clustering method 
needs to be chosen with consideration because it can greatly influence the outcome 
and meaning of the analysis. Many clustering methods are available, such as k-means, 
self-organizing maps (SOM) and etc. In this paper, we use k-means as our clustering 
algorithm because it is faster and produce tighter clusters than other clustering meth-
ods [23, 24, 25]. Modules can subsequently be interpreted by functional enrichment 
analysis, a method to identify and rank overrepresented functional categories in a list 
of genes [16, 17]. 
3 Experiment 
The datasets we used in our experiments are the level 3 data of three types of cancer 
from The Cancer Genome Atlas (TCGA): Rectum adenocarcinoma (READ), Breast 
invasive carcinoma (BRCA) and Colon adenocarcinoma (COAD). For each type of 
cancer, cancer samples and normal samples are randomly picked up from the same 
batch. Table 1 lists the number of selected genes and samples. 
Table 1. Number of genes and samples selected 
No Cancer Gene Number Caner Sample Normal Sample 
1 BCRA 17814 10 10 
2 COAD 17814 10 10 
3 READ 17814 10 3 
Total 53442 30 23 
The database does not supply enough number of normal samples for READ, so we 
only use three normal samples as the comparison with cancer samples. Besides, all the 
gene expression data are detected by Agilent microarrays with the same processing 
and normalization way by the following formula shows, so they are comparable. 
𝑙𝑜𝑔2 (
𝐶𝑦5
𝐶𝑦3
) = 𝑙𝑜𝑔2 (
𝑠𝑎𝑚𝑝𝑙𝑒
𝑐𝑜𝑛𝑡𝑟𝑜𝑙
) 
187
3.1 Find Genes Expressed Differently between Cancer and Normal Samples 
Firstly, we want to find the genes expressed differently between cancer and normal 
samples since these genes are more possible to be the target genes than those with the 
similar expressions between cancer samples and normal samples.  
T-test can be used here to determine if two sets of data are significantly different
from each other. Before doing T-test, we need to use F-test to examine the homogene-
ity of variance between two data sets. We select the data with p value larger than 0.05 
after T-test. Table 2 shows the number of genes left.  
Table 2. Number of genes left after t-test 
No Gene Original After F-test After T-test 
1 BCRA 17814 12208 4535 
2 COAD 17814 12721 6635 
3 READ 17814 16349 4939 
Total 53442 41278 16109 
3.2 Select Common Genes among Different Cancers 
Next, we select the genes appeared in all the three gene sets and called them “com-
mon genes”, because we are interested in finding the common patterns across multiple 
cancer types. 878 common genes are then selected from 16109 genes obtained in last 
step after T-test. Table 3 lists the results.  
Table 3. Number of genes appeared in different cancer sets 
Genes Number 
Appear in Only One Cancers 6676 
Appear in Only Two Cancers 3398 
Appear in All Three Cancers 878 
We then list the cancer samples expressed by each gene of the three types of cancers, 
and obtain a gene-expression matrix with 878 rows and 30 columns, where the gene 
expression data of each type of cancer are represented by 10 columns of values. 
3.3 Cluster Common Genes 
With the common gene expression matrix, we can find the closely related genes with 
similar gene expression through clustering, which might give us clues of seeking bio-
events for cancers. We use Pearson Correlation as the gene similarity metric and k-
means as the clustering algorithm with the number of clusters set to 20. We use the 
SPSS Statistics software package (version 22) to process the data and export the anal-
ysis results. After clustering, we have 814 genes valid (92.7 %) and 64 genes missing 
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(7.3%). It shows that most of the genes have high correlation and can be clustered into 
multiple groups. Fig. 1 shows the gene network. 
Fig. 1. Common gene network of selected 878 genes 
In each cluster, we chose the pair of genes with highest coefficient as Table 4 shows. 
These genes may be related to the cancer specific bio-events, and we will discuss the 
significance of them in next section. 
Table 4. Pair of genes with highest coefficient in each cluster 
Cluster Pair of Genes Coefficient 
Cluster1 MT1H MT1B 0.984 
Cluster2 PTTG3 PTTG1 0.982 
Cluster3 PDGFD APOD 0.941 
… … … … 
Cluster20 FBLN5 RBMS3 0.935 
3.4 Cluster Samples 
Besides clustering genes, we also try to find whether there are some interesting results 
by clustering samples. We first transpose gene-expression matrix, and then use the 
Pearson Correlation as the similarity metric and Between-Groups Linkage as the clus-
tering algorithm. We only have 1 case missing and obtained a valid rate of 96.7 % for 
all the 30 samples. Figure 2 shows the dendrogram of clustering result. We can see 
that there are basically two groups of samples after clustering.  
The significance of the clustering is evaluated by its statistical results. The results 
are basically classified into two classes: “between groups” and “within groups” val-
ues. We want the clusters with short “within group” linkage and long “between 
group” linkage. There are only one sample out of thirty with p value larger than 0.05: 
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READ-TCGA-AF-3400-01A-01R-0821-07 with 0.8. The p values of the all rest sam-
ples are less than 0.05, making the clustering significance to be 96.7%.  
Fig. 2. Dendrogram of the clustering result 
4 Analysis 
We respectively choose three pairs of genes from three clusters: APOD and PDGFD, 
RBMS3 and FBLN5, TUBB6 and DDR2. Genes in each pair are highly related to 
each other, meaning their expression patterns are similar in all cases. As shown in Fig 
3, each pair of genes is positively related under each type of cancer. Additionally, the 
values and relationships of gene expressions are closer in cancer COAD and READ, 
and separated from BRCA. It corresponds to the fact that rectum is a part of colon, so 
the origins of COAD and READ are closer, and they may share lots of commons. 
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 Fig. 3. Gene co-expression in three types of cancers 
Let’s focus on each pair of genes separately. In the first pair, PDGFD encodes platelet 
derived growth factor D, which promotes cancer progression [19]. Compared to nor-
mal samples, PDGFD is down regulated in the cancer samples. However, it makes no 
sense because cancer cells tend to grow rapidly and uncontrolledly, so it may up-
regulate the gene expression of growth factors. APOD – apolipoprotein D is a good 
prognostic marker, and it is expressed differently in COAD and READ cancer sam-
ples, which may represent different patient prognosis conditions.  Other genes such as 
FBLN5 – fibulin 5, plays a role in proliferation, migration and invasion [20], TUBB6 
– tubulin beta 6, malignant transformation and drug resistance and DDR2 – discoidin
domain receptor try kinase 2, which promotes matastasis. According to the other re-
search, all these genes should contribute to cancer cells progression, but they are
down regulated in the cancer samples. It may be explained by fact that patients are
receiving treatments and they are turning good, so the genes promoting cancer pro-
gression are down regulated. In terms of RBMS3 – single stranded interacting protein
3 that inhibits cell proliferation is also down regulated, but it makes sense because this
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protein is encoded by the gene serve as a tumor suppressor. Figure 4 shows the differ-
ence of these gene expressed in normal and cancer samples. 
PDGFD 
APOD 
RBMS3 
FBLN5 
TUBB6 
DDR2 
Fig. 4. Gene expression in normal (blue color) and cancer samples (red color) for three types of 
cancer: COAD, READ and BRCA 
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From the clustering result of sample in Figure 2, we can see that COAD and READ 
have closer relationships, and the patients of these two cancers mix together, while 
BRCA forms a separate cluster as Table 5 shows, that is an evidence of the above 
analysis. 
Table 5. Clustering results of samples 
Cluster 
Number of Cancer Samples 
COAD READ BRCA 
Cluster1 10 9 0 
Cluster2 0 0 10 
5 Discussion 
We study the real functions of the genes selected from each cluster by searching the 
National Center for Biotechnology Information (NCBI) database, and pay more atten-
tion to the genes that are cell essential or related to disease. In one cluster, two genes 
are found related to tumor suppression and migration. FLNA encodes filamin A, al-
pha, that is involved in remodeling the cytoskeleton to effect changes in cell shape 
and migration. Previous research shows that FLNA plays an important role in cancer 
proliferation and metastasis [18]. FLNA also interacts with oncogenesis and metasta-
sis related proteins, meaning that it is essential for cancer progression. GAS1 is 
growth arrest-specific 1 which encodes GAS1 protein to blocks cells to enter S phase, 
so it is considered as a tumor suppress gene, and previous research suggests that 
GAS1 expression significantly reduce the colony-forming ability of gastric cancer 
cells in vitro and cell growth in vivo [21]. In Figure 5, we can see that in BRCA can-
cer, FLNA and GAS1 are positive related. In COAD and READ, it seems that FLNA 
and GAS1 do not have any relevance but their expression values are close to each 
other according to the dataset.  
Fig. 5. Expression of gene FLNA and GAS1 in three types of cancers 
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In the future, we are interested in using machine learning methods [22, 26, 27, 31] to 
find more possible gene signatures, and combine the medical knowledge to explain 
them [28, 30]. 
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